Article

Pan-cancer machine learning predictors of primary site of origin and molecular subtype

2018-05-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> It is estimated by the American Cancer Society that approximately 5% of all metastatic tumors have no defined primary site (tissue) of origin and are classified as c ancers of u nknown p rimary (CUPs). The current standard of care for CUP patients depends on immunohistochemistry (IHC) based approaches to identify the primary site. The addition of post-mortem evaluation t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 467ebdaa-044b-5bd7-b5d5-26a4025e8b90
DOI: 10.1101/333914

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer machine learning predictors of primary site of origin and molecular subtypeDOI 10.1101/333914Read

Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-OriginSemantic proximity Read

Cancer of unknown primary.Semantic proximity Read

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence eraSemantic proximity Read

Deep Learning Based Identification of Tissue of Origin for Carcinomas of Unknown Primary utilizing micro-RNA expressionSemantic proximity Read

Application of Transcriptome–Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic CancerSemantic proximity Read

ISOLATE: a computational strategy for identifying the primary origin of cancers using high-throughput sequencingSemantic proximity Read

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceSemantic proximity Read

An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown OriginSemantic proximity Read

Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor typeSemantic proximity Read

Predicting Tissue of Origin from Bulk Tumor Gene Expression using a Pre-trained Transformer ModelSemantic proximity Read

Tumor Origin Detection with Tissue-Specific miRNA and DNA methylation MarkersSemantic proximity Read

Machine learning of genomic features in organotropic metastases stratifies progression risk of primary tumors.Semantic proximity Read